Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth B Sobolik

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos Pathogens|January 13, 2025
Mutations in chikungunya virus nsP4 decrease viral fitness and sensitivity to the broad-spectrum antiviral 4'-FluorouridinePeiqi Yin, Elizabeth B Sobolik, Nicholas A May, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
DEVELOPMENT OF A POTENT MONOCLONAL ANTIBODY FOR TREATMENT OF HUMAN METAPNEUMOVIRUS INFECTIONSEvelyn D Harris, Morgan McGovern, Sara Pernikoff, et al.
Journal of Virology|August 29, 2024
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infectionCarolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infectionCarolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Science (New York, N.Y.)|June 27, 2024
A neutralizing antibody prevents postfusion transition of measles virus fusion proteinDawid S Zyla, Roberta Della Marca, Gele Niemeyer, et al.
Nature Communications|February 8, 2024
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferretsRobert M Cox, Josef D Wolf, Nicole A Lieberman, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos Pathogens|January 13, 2025
Mutations in chikungunya virus nsP4 decrease viral fitness and sensitivity to the broad-spectrum antiviral 4'-FluorouridinePeiqi Yin, Elizabeth B Sobolik, Nicholas A May, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
DEVELOPMENT OF A POTENT MONOCLONAL ANTIBODY FOR TREATMENT OF HUMAN METAPNEUMOVIRUS INFECTIONSEvelyn D Harris, Morgan McGovern, Sara Pernikoff, et al.
Journal of Virology|August 29, 2024
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infectionCarolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infectionCarolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Science (New York, N.Y.)|June 27, 2024
A neutralizing antibody prevents postfusion transition of measles virus fusion proteinDawid S Zyla, Roberta Della Marca, Gele Niemeyer, et al.
Nature Communications|February 8, 2024
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferretsRobert M Cox, Josef D Wolf, Nicole A Lieberman, et al.
Pageof 2